Clinical Considerations and Management of Lp(a)

Clinical Considerations and Management of Lp(a)

In November 2020, the National Lipid Association convened a global Think Tank comprised of 7 stakeholder organizations with a mission to:

  • Inform a globally accepted expert consensus on the measurement and management of Lipoprotein(a) in clinical practice
  • Recommend and create consensus resources for clinicians

Joseph J. Saseen, PharmD, CLS, FNLA
Salim S. Virani, MD, PhD, FACC, FAHA, FASPC

Stakeholder Organizations:
Association of Black Cardiologists (ABC)
American College of Cardiology (ACC)
American Heart Association (AHA)
European Atherosclerosis Society (EAS)
International Atherosclerosis Society (IAS)
National Institutes of Health (NIH)
Preventive Cardiovascular Nurses Association (PCNA)

The resource(s) below have been provided as a result of the work of this Think Tank.



Please note that unless expressly stated, the viewpoints and education provided within these resources should not be interpreted as official positions of the Stakeholder Organizations. 

Publish Date: 
Monday, May 17, 2021 - 14:15

This page was last updated: Jul 26, 2021